Skip to content

Human clinical Trial for the efficacy of AUL NiacinGold™ Sun Screen in alleviation of photoaging caused by ultraviolet (UV) rays after 2 weeks of use

Human clinical Trial for the efficacy of AUL NiacinGold™ Sun Screen in alleviation of photoaging caused by ultraviolet (UV) rays after 2 weeks of use

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0012184
Enrollment
44
Registered
2026-06-26
Start date
2025-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others( A (AUL NiacinGold™ Sun Screen) and B (non-application) comparison) : In this study, the back area of each subject was divided into two halves. One side was designated as the test site, to whic

Sponsors

Human Co., Ltd. Skin Clinical Trial Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Healthy Korean males and female adult over the age of 19 years - Subjects who have signed consent form voluntarily after being informed sufficiently on the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases including skin disorders - Subjects who can be observed and traced throughout the entire study period

Exclusion criteria

Exclusion criteria: - Subjects who are and/or have plan of pregnant or breast-feeding - Subjects who have psychiatric disease and infectious skin disease - Subjects who have used an ointment containing steroids for more than 1 month - Subjects who participated in the similar test within the past 6 months - Subjects who have sensitive and hypersensitive skin - Subjects who have skin disorders on the test site such as moles, pimples, red spots, scalds (burns), hemotelangiosis, and scars - Subjects who have used cosmetics or drugs on the test site with similar efficacy within the past 3 months - Subjects who received treatment from dermatologist or aestheticians on the test site within the past 6 months - Those who are employed in this clinical trial center - Those who are considered as a nonqualified person by judge or the investigator

Design outcomes

Primary

MeasureTime frame
Skin texture (roughness);Skin soothing (redness);Skin moisture content;Skin moisture loss

Secondary

MeasureTime frame
Efficacy self report questionnaire;Assessment of skin adverse reaction

Countries

Korea, Republic of

Contacts

Public ContactKim Suyeong

Human Co., Ltd. Skin Clinical Trial Center

ksy1@humantest.co.kr+82-70-8664-1074

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 3, 2026